fashion -WSS

fashion

author：hotspot 2025-10-01 04:09:59 - browse：3

After earning her doctorate in cell biology at the University of Pennsylvania in June, Sierra Collins did what many freshly minted Ph.D.s. do — she went looking for a job at a biotech company. But what was supposed to be a straightforward search has turned into an odyssey.

Collins has applied for more than 53 positions (and counting). Like a good scientist, she’s gathering data along the way and uses a spreadsheet to track each company’s size and therapeutic focus, as well as whether she was referred for the position and how far she made it through the application process. So far, those efforts have been unsuccessful.

“I try my best not to take it personally. These are companies that are trying to find an employee who’s going to help them achieve their business goals,” Collins said. “But it is pretty discouraging just repeatedly getting turned down, especially at later stages of the interview process.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

WSS

Alexander Hamilton and the argument for universal insurance

Histogen: Failed biotech offers rare public look inside

Histogen: Failed biotech offers rare public look inside

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

The mammogram wars are not over

The future of health care in the House

Wikipedia

fashion

explore

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

VC firm RA Capital starts a new synthetic biology incubator

After affirmative action ruling, medical educators look to 'holistic review'

Ending health disparities requires full federal government, panel says

Psychedelics group wrestles with new pharma identity

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

As demand for Covid shots wanes, Moderna seeks its next success

Was Amgen transparent enough on FDA's concern on cancer drug?

DIEP, the 'gold standard' of breast reconstruction, is under threat

Biden to sign 'historic' executive order on how US military handles sexual assault cases

focus

Stoke drug shows lower activity against childhood epilepsy

Why age limits for politicians are a terrible idea

Bill would stop addiction treatment from triggering child abuse inquiry

Biden jokes that Republicans may impeach him because inflation is starting to cool down

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Analysis of telehealth claims data suggest service duplication

Wikipedia

focus

entertainment

hotspot